Dr. Simon Carlo, M.D

NPI: 1548350564
Total Payments
$4,588
2024 Payments
$69.02
Companies
6
Transactions
19

Payment Breakdown by Category

Other$2,300 (50.1%)
Consulting$1,776 (38.7%)
Food & Beverage$512.36 (11.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,300 1 50.1%
Consulting Fee $1,776 1 38.7%
Food and Beverage $512.36 17 11.2%

Top Paying Companies

Company Total Records Latest Year
GENZYME CORPORATION $4,154 4 $0 (2023)
Takeda Pharmaceuticals U.S.A., Inc. $212.61 11 $0 (2024)
Biogen, Inc. $100.00 1 $0 (2022)
PFIZER INC. $55.20 1 $0 (2019)
Merck Sharp & Dohme LLC $49.55 1 $0 (2023)
AbbVie, Inc. $17.28 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $69.02 3 Takeda Pharmaceuticals U.S.A., Inc. ($69.02)
2023 $2,438 6 GENZYME CORPORATION ($2,332)
2022 $131.85 3 Biogen, Inc. ($100.00)
2021 $11.20 1 Takeda Pharmaceuticals U.S.A., Inc. ($11.20)
2020 $44.58 2 Takeda Pharmaceuticals U.S.A., Inc. ($44.58)
2019 $1,877 3 GENZYME CORPORATION ($1,822)
2018 $17.28 1 AbbVie, Inc. ($17.28)

All Payment Transactions

19 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
10/01/2024 Takeda Pharmaceuticals U.S.A., Inc. VPRIV (Biological) Food and Beverage In-kind items and services $18.97 General
Category: GENETIC DISEASE
09/03/2024 Takeda Pharmaceuticals U.S.A., Inc. VPRIV (Biological) Food and Beverage In-kind items and services $32.69 General
Category: GENETIC DISEASE
02/13/2024 Takeda Pharmaceuticals U.S.A., Inc. VPRIV (Biological) Food and Beverage In-kind items and services $17.36 General
Category: GENETIC DISEASE
10/03/2023 Takeda Pharmaceuticals U.S.A., Inc. VPRIV (Biological) Food and Beverage In-kind items and services $20.19 General
Category: GENETIC DISEASE
09/04/2023 GENZYME CORPORATION Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,300.00 General
09/04/2023 GENZYME CORPORATION Food and Beverage In-kind items and services $32.15 General
09/02/2023 Merck Sharp & Dohme LLC VAXNEUVANCE (Biological) Food and Beverage In-kind items and services $49.55 General
Category: INFECTIOUS DISEASE
07/11/2023 Takeda Pharmaceuticals U.S.A., Inc. VPRIV (Biological) Food and Beverage In-kind items and services $18.66 General
Category: GENETIC DISEASE
06/27/2023 Takeda Pharmaceuticals U.S.A., Inc. VPRIV (Biological) Food and Beverage In-kind items and services $17.11 General
Category: GENETIC DISEASE
11/16/2022 Biogen, Inc. SPINRAZA (Biological) Food and Beverage In-kind items and services $100.00 General
Category: Neurology
11/03/2022 Takeda Pharmaceuticals U.S.A., Inc. VPRIV (Biological) Food and Beverage In-kind items and services $16.31 General
Category: GENETIC DISEASE
08/30/2022 Takeda Pharmaceuticals U.S.A., Inc. VPRIV (Biological) Food and Beverage In-kind items and services $15.54 General
Category: GENETIC DISEASE
05/25/2021 Takeda Pharmaceuticals U.S.A., Inc. VPRIV (Biological) Food and Beverage In-kind items and services $11.20 General
Category: GENETIC DISEASE
09/29/2020 Takeda Pharmaceuticals U.S.A., Inc. VPRIV (Biological) Food and Beverage In-kind items and services $22.47 General
Category: GENETIC DISEASE
08/25/2020 Takeda Pharmaceuticals U.S.A., Inc. VPRIV (Biological) Food and Beverage In-kind items and services $22.11 General
Category: GENETIC DISEASE
11/20/2019 GENZYME CORPORATION DISEASE STATE (Drug) Consulting Fee Cash or cash equivalent $1,776.00 General
11/20/2019 GENZYME CORPORATION DISEASE STATE (Drug) Food and Beverage In-kind items and services $45.57 General
04/24/2019 PFIZER INC. PREVNAR 13 (Biological) Food and Beverage In-kind items and services $55.20 General
Category: VACCINES
08/15/2018 AbbVie, Inc. Mavyret (Drug) Food and Beverage In-kind items and services $17.28 General
Category: Virology

About Dr. Simon Carlo, M.D

Dr. Simon Carlo, M.D is a General Practice healthcare provider based in Hormigueros, Puerto Rico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1548350564.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Simon Carlo, M.D has received a total of $4,588 in payments from pharmaceutical and medical device companies, with $69.02 received in 2024. These payments were reported across 19 transactions from 6 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($2,300).

Practice Information

  • Specialty General Practice
  • Location Hormigueros, PR
  • Active Since 10/13/2006
  • Last Updated 01/30/2008
  • Taxonomy Code 208D00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1548350564

Products in Payments

  • DISEASE STATE (Drug) $1,822
  • VPRIV (Biological) $212.61
  • SPINRAZA (Biological) $100.00
  • PREVNAR 13 (Biological) $55.20
  • VAXNEUVANCE (Biological) $49.55
  • Mavyret (Drug) $17.28

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

General Practice Doctors in Hormigueros